Profil bibliographique

Dominick Latrémouille-Viau

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

171Publications signalées

1163Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia ResearchAcute Myeloid Leukemia ResearchAcute Lymphoblastic Leukemia researchComplement system in diseases

Publications récentes

2026 articleOpenAlex

POSTER: CML-692: Asciminib in Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase: A Retrospective Chart Review Study in the US

Ehab Atallah, Andrea Damon, Daisy Yang, Dominick Latrémouille-Viau et autres

0 citationsClinical Lymphoma Myeloma & Leukemia

2026 conference-abstractOpenAlex

CML-692: Asciminib in Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase: A Retrospective Chart Review Study in the US

Ehab Atallah, Andrea Damon, Daisy Yang, Dominick Latrémouille-Viau et autres

0 citationsClinical Lymphoma Myeloma & Leukemia

2026 articleOpenAlex

POSTER: CML-694: Adherence of Asciminib vs ATP-Competitive Tyrosine Kinase Inhibitors in Second Line for Chronic Myeloid Leukemia in Chronic Phase

Akriti G Jain, David Wei, Dominick Latrémouille-Viau, Carmine Rossi et autres

0 citationsClinical Lymphoma Myeloma & Leukemia

2026 conference-abstractOpenAlex

CML-694: Adherence of Asciminib vs ATP-Competitive Tyrosine Kinase Inhibitors in Second Line for Chronic Myeloid Leukemia in Chronic Phase

Akriti G Jain, David Wei, Dominick Latrémouille-Viau, Carmine Rossi et autres

0 citationsClinical Lymphoma Myeloma & Leukemia

2026 articleOpenAlex

Asciminib in newly diagnosed Philadelphia chromosom–positive chronic myeloid leukemia in chronic phase (Ph+ CML-CP): A retrospective chart review study in the US.

Ehab Atallah, Islam Sadek, Andrea Damon, Daisy Yang et autres

0 citationsJournal of Clinical Oncology

Accès ouvert 2026 articleOpenAlex

Patient-reported time toxicity with bispecific antibody therapies in relapsed/refractory follicular lymphoma and diffuse large B-cell lymphoma

Ajay Major, Esprit Ma, Anthony Masaquel, Mazie Tsang et autres

1 citationThe Oncologist

Accès ouvert 2025 conference-abstractOpenAlex

Association between increased Patients' out-of-pocket costs for apixaban and oral anticoagulant discontinuation in high-risk patients with atrial fibrillation - a retrospective Medicare claims study

Dominick Latrémouille-Viau, Aolin Wang, Dong Cheng, Serina Deeba et autres

0 citationsBlood

2025 conference-abstractOpenAlex

A comparison of real-world outcomes of asciminib versus ATP-competitive tyrosine kinase inhibitors as second-line treatment in patients with chronic myeloid leukemia in chronic phase

Ehab Atallah, Islam Mohamad Sadek, Emily McGovern, Dominick Latrémouille-Viau et autres

0 citationsBlood

Accès ouvert 2025 conference-abstractOpenAlex

The humanistic burden of patients with chronic myeloid leukemia (CML) treated with first line (1L) tyrosine kinase inhibitors (TKIs)

Kelly L. Schoenbeck, Joan Clements, Karen DeMairo, David Wei et autres

0 citationsBlood

Accès ouvert 2025 conference-abstractOpenAlex

Real-world analysis of asciminib as first-line therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phase: A chart review Study in the United States

Ehab Atallah, Islam Mohamad Sadek, Emily McGovern, Dominick Latrémouille-Viau et autres

0 citationsBlood

Accès ouvert 2025 articleOpenAlex

Impact of increased patient out-of-pocket costs on oral anticoagulant discontinuation among Medicare beneficiaries with atrial fibrillation treated with apixaban

Dominick Latrémouille-Viau, Aolin Wang, Dong Cheng, Serina Deeba et autres

0 citationsCurrent Medical Research and Opinion

Accès ouvert 2025 articleOpenAlex

Treatment with asciminib after a prior tyrosine kinase inhibitor in patients with chronic-phase chronic myeloid leukemia

Ehab Atallah, Islam Sadek, David Wei, Dominick Latrémouille-Viau et autres

2 citationsLeukemia Research

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.